NCT01730716View on ClinicalTrials.gov

Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis

PHASE2UnknownINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

November 30, 2016

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DEVICE

Human spinal cord stem cell implantation

Human spinal cord stem cell implantation in ALS patients.

Trial Locations (3)

30322

Emory University, Atlanta

48109

University of Michigan, Ann Arbor

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

Neuralstem Inc.
All Listed Sponsors
lead

Neuralstem Inc.

INDUSTRY